制药(BK4007)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BK4007 制药

休市中 01-23 16:00:00 EST

856.97

-3.28

-0.38%

最高861.95	最低853.57	成交量3.39亿
今开860.18	昨收860.25	日振幅0.97%
总市值0.00	流通市值0.00	总股本0.00
成交额132.67亿	换手率--	流通股本0.00
市净率5.475789	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BK4007","market":"US","secType":"PLATE","nameCN":"制药","latestPrice":856.9699,"timestamp":1769201999999,"preClose":860.25146,"halted":0,"volume":338977452,"delay":0,"changeRate":-0.003815,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":-3.281555,"latestTime":"01-23 16:00:00 EST","open":860.1844,"high":861.94824,"low":853.5704,"amount":13267289300.275314,"amplitude":0.009739,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1769418000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.475789,"peRate":26.172073,"increases":0,"decrements":0,"flats":0},"requestUrl":"/m/hq/s/BK4007","defaultTab":"news","newsList":[{"id":"2606256672","title":"VanEck Avalanche 现货 ETF 将于纳斯达克上市交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2606256672","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606256672?lang=zh_cn&edition=full","pubTime":"2026-01-25 13:12","pubTimestamp":1769317973,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，VanEck Avalanche 现货 ETF（简称 VanEck Avalanche ETF，代码 VAVX）将于下周一在纳斯达克正式开始上市交易。Flow Traders 被指定为该 ETF 的主要做市商。 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2240263","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSQ","TQQQ","USJW.SI","QID","QQQJ","MNQmain","BK4007","JEPQ","USAW.SI","QQQY","BK1147","BK4585","BK4550","QQQE","BK4588","QLD","QYLD","GPIQ","TSYW.SI","QYLG","SQQQ","NVIW.SI"],"gpt_icon":0},{"id":"2605298238","title":"诺和诺德口服Wegovy上市首个完整周处方超1.8万，显著领先其他GLP-1药物同期表现","url":"https://stock-news.laohu8.com/highlight/detail?id=2605298238","media":"Minhua笔记","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605298238?lang=zh_cn&edition=full","pubTime":"2026-01-24 15:24","pubTimestamp":1769239499,"startTime":"0","endTime":"0","summary":"诺和诺德的口服Wegovy上市头11天的早期处方数据超出市场预期，显著领先礼来替尔泊肽注射剂同期表现。1月23日发布的一份分析报告显示，口服Wegovy在截至1月16日的一周内共开出了18,410张处方——这是该药自1月5日上市以来的第一个完整周。按照目前的每周处方量来看，口服Wegovy的处方量已经接近Rybelsus总处方量5万张的一半。这款口服减重药的上市进展目前远超之前的其他GLP-1类药物。更重要的是，它并未导致注射用Wegovy的处方量下滑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012415293997a3351b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012415293997a3351b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4144","BK4532","LU1093756325.SGD","BK4588","IE00BKVL7J92.USD","LU1093756168.USD","BK4590","IE00BZ1G4Q59.USD","LU0154236417.USD","NVO","BK4585","BK4007","BK4599"],"gpt_icon":1},{"id":"1136775542","title":"Roivant Sciences将于2026年2月6日公布2025财年第三季度业绩并举行业务更新会","url":"https://stock-news.laohu8.com/highlight/detail?id=1136775542","media":"美股速递","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136775542?lang=zh_cn&edition=full","pubTime":"2026-01-24 05:15","pubTimestamp":1769202912,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd. (ROIV) 计划于2026年2月6日（星期五）发布其截至2025年12月31日的2025财年第三季度财务业绩报告。届时，公司管理层还将同步举行业务更新会议，向投资者和市场详细通报公司的最新运营进展与战略规划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV","BK4007","BK4139"],"gpt_icon":0},{"id":"1121506195","title":"Journey Medical Corp签署销售协议 拟发售最多375万股普通股——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1121506195","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121506195?lang=zh_cn&edition=full","pubTime":"2026-01-24 05:12","pubTimestamp":1769202734,"startTime":"0","endTime":"0","summary":"根据最新提交至美国证券交易委员会（SEC）的文件显示，Journey Medical Corp已正式签署一项股权销售协议。该公司计划通过该协议向市场公开发行并出售其普通股，规模最高可达375万股。此次股票发售将依据相关证券法规进行，具体条款及资金用途有待进一步披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DERM","BK4007"],"gpt_icon":0},{"id":"2605281901","title":"Ataibeckley Inc.盘中异动 临近收盘急速拉升5.04%报4.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605281901","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605281901?lang=zh_cn&edition=full","pubTime":"2026-01-24 04:55","pubTimestamp":1769201723,"startTime":"0","endTime":"0","summary":"北京时间2026年01月24日04时55分，Ataibeckley Inc.股票出现波动，股价大幅上涨5.04%。截至发稿，该股报4.17美元/股，成交量443.616万股，换手率1.22%，振幅6.68%。Ataibeckley Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Ataibeckley Inc.公司简介：AtaiBeckley Inc是一家处于临床试验阶段的生物制药企业，其使命是通过研发有效、见效迅速且便捷的心理健康治疗方案来改善患者状况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124045523a44f889a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124045523a44f889a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["R","BK4007","BK4539","BK4022","ATAI","BK4232"],"gpt_icon":0},{"id":"2605323537","title":"Viking Therapeutics, Inc.盘中异动 大幅下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605323537","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605323537?lang=zh_cn&edition=full","pubTime":"2026-01-24 04:30","pubTimestamp":1769200210,"startTime":"0","endTime":"0","summary":"北京时间2026年01月24日04时30分，Viking Therapeutics, Inc.股票出现波动，股价快速下跌5.00%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124043011a44f7ec4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124043011a44f7ec4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4599","BK4588","BK4585","BK4139","LENZ","VKTX","BK4007"],"gpt_icon":0},{"id":"2605284724","title":"Foghorn Therapeutics Inc.盘中异动 快速跳水5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605284724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605284724?lang=zh_cn&edition=full","pubTime":"2026-01-24 04:00","pubTimestamp":1769198414,"startTime":"0","endTime":"0","summary":"北京时间2026年01月24日04时00分，Foghorn Therapeutics Inc.股票出现异动，股价急速跳水5.16%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.58%。其相关个股中，Coherus Oncology, Inc.、Collplant Biotechnologies Ltd.、Scinai Immunotherapeutics Ltd涨幅较大，Revelation Biosciences, Inc.、60 Degrees Pharmaceuticals, Inc.、Aditxt, Inc.较为活跃，换手率分别为1447.84%、165.05%、50.83%，振幅较大的相关个股有Revelation Biosciences, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为99.49%、60.41%、58.89%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124040014a44f739a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124040014a44f739a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FHTX","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"2605893238","title":"Jupiter Neurosciences, Inc.盘中异动 下午盘股价大跌5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605893238","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605893238?lang=zh_cn&edition=full","pubTime":"2026-01-24 02:40","pubTimestamp":1769193640,"startTime":"0","endTime":"0","summary":"北京时间2026年01月24日02时40分，Jupiter Neurosciences, Inc.股票出现异动，股价急速下挫5.88%。Jupiter Neurosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.77%。其相关个股中，Revelation Biosciences, Inc.、Coherus Oncology, Inc.、天演药业涨幅较大，Revelation Biosciences, Inc.、60 Degrees Pharmaceuticals, Inc.、Aditxt, Inc.较为活跃，换手率分别为1202.83%、154.48%、47.82%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 26/02/2026、Revelation Biosciences Inc C/Wts 10/01/2027 、Revelation Biosciences, Inc.，振幅分别为60.41%、58.89%、50.33%。Jupiter Neurosciences, Inc.公司简介：Jupiter Neurosciences Inc 是一家位于佛罗里达州朱庇特的临床阶段研发制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124024040953e2121&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124024040953e2121&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","JUNS"],"gpt_icon":0},{"id":"2605236552","title":"Lenz Therapeutics, Inc.盘中异动 大幅跳水5.03%报20.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605236552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605236552?lang=zh_cn&edition=full","pubTime":"2026-01-24 02:25","pubTimestamp":1769192712,"startTime":"0","endTime":"0","summary":"北京时间2026年01月24日02时25分，Lenz Therapeutics, Inc.股票出现波动，股价快速下跌5.03%。Lenz Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.88%。其相关个股中，Revelation Biosciences, Inc.、Coherus Oncology, Inc.、天演药业涨幅较大，Revelation Biosciences, Inc.、60 Degrees Pharmaceuticals, Inc.、Aditxt, Inc.较为活跃，换手率分别为1193.68%、151.85%、46.49%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 26/02/2026、Revelation Biosciences Inc C/Wts 10/01/2027 、Revelation Biosciences, Inc.，振幅分别为60.41%、58.89%、50.33%。Lenz Therapeutics, Inc.公司简介：LENZ Therapeutics Inc是一家后期生物制药公司，专注于开发和商业化改善视力的疗法以及开发眼科药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012402251297a32c17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012402251297a32c17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","BK4539"],"gpt_icon":0},{"id":"2605283236","title":"Transcode Therapeutics, Inc.盘中异动 快速拉升7.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605283236","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605283236?lang=zh_cn&edition=full","pubTime":"2026-01-24 01:43","pubTimestamp":1769190216,"startTime":"0","endTime":"0","summary":"北京时间2026年01月24日01时43分，Transcode Therapeutics, Inc.股票出现异动，股价大幅上涨7.30%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.90%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc是一家生物制药公司，专注于开发和商业化用于癌症治疗和诊断的创新药物和诊断工具。TransCode最近启动了其首次临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124014337953e20eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124014337953e20eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","RNAZ","BK4539","LENZ"],"gpt_icon":0},{"id":"2605235183","title":"Cingulate Inc.盘中异动 早盘股价大跌5.40%报5.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605235183","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605235183?lang=zh_cn&edition=full","pubTime":"2026-01-23 23:45","pubTimestamp":1769183131,"startTime":"0","endTime":"0","summary":"北京时间2026年01月23日23时45分，Cingulate Inc.股票出现波动，股价快速跳水5.40%。截至发稿，该股报5.08美元/股，成交量9.1749万股，换手率1.23%，振幅5.77%。Cingulate Inc.股票所在的生物技术行业中，整体跌幅为0.33%。Cingulate Inc.公司简介：Cingulate Inc是一家临床阶段的生物制药公司，利用其专有的精准定时释放药物递送平台来建立和推进下一代药物产品管线，旨在改善那些因每日繁琐的给药方案和治疗效果不佳而痛苦的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012323453197a32ac9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012323453197a32ac9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CING","ADHD","BK4007"],"gpt_icon":0},{"id":"2605728074","title":"Jaguar Health, Inc.盘中异动 急速拉升5.90%报0.773美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605728074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605728074?lang=zh_cn&edition=full","pubTime":"2026-01-23 23:32","pubTimestamp":1769182341,"startTime":"0","endTime":"0","summary":"北京时间2026年01月23日23时32分，Jaguar Health, Inc.股票出现异动，股价快速上涨5.90%。Jaguar Health, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Jaguar Health, Inc.公司简介：Jaguar Health Inc 是一家商业阶段的制药公司，专注于为患有胃肠道疾病的人和动物开发新型、植物性、非阿片类药物且可持续衍生的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123233221a44f0231&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123233221a44f0231&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JAGX","BK4007"],"gpt_icon":0},{"id":"2605428991","title":"Camp4 Therapeutics Corporation盘中异动 早盘快速下挫7.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605428991","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605428991?lang=zh_cn&edition=full","pubTime":"2026-01-23 23:17","pubTimestamp":1769181423,"startTime":"0","endTime":"0","summary":"北京时间2026年01月23日23时17分，Camp4 Therapeutics Corporation股票出现异动，股价快速下跌7.28%。Camp4 Therapeutics Corporation股票所在的生物技术行业中，整体跌幅为0.19%。Camp4 Therapeutics Corporation公司简介：Camp4 Therapeutics Corp是一家临床阶段的生物制药公司，致力于发现和开发基于RNA的疗法，通过上调基因表达和恢复健康的蛋白质水平来治疗各种遗传疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123231704a44ef917&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123231704a44ef917&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4020","BK4139","BK4007","CAMP"],"gpt_icon":0},{"id":"2605140947","title":"诺和诺德盘中异动 股价大涨3.04%报64.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605140947","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605140947?lang=zh_cn&edition=full","pubTime":"2026-01-23 23:11","pubTimestamp":1769181061,"startTime":"0","endTime":"0","summary":"北京时间2026年01月23日23时11分，诺和诺德股票出现波动，股价快速上涨3.04%。截至发稿，该股报64.12美元/股，成交量602.618万股，换手率0.14%，振幅1.32%。诺和诺德股票所在的制药行业中，整体涨幅为0.05%。诺和诺德公司简介：诺和诺德在全球品牌糖尿病治疗市场中占据大约三分之一的份额，是世界上领先的糖尿病护理产品供应商。诺和诺德还拥有一个生物制药部门，专注于治疗血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123231101a44ef5a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123231101a44ef5a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4532","IE00BKVL7J92.USD","LU0154236417.USD","IE00BZ1G4Q59.USD","LU1093756325.SGD","LU1093756168.USD","BK4585","BK4599","BK4007","NVO"],"gpt_icon":1},{"id":"2605239143","title":"苏轩堂盘中异动 股价大跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605239143","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605239143?lang=zh_cn&edition=full","pubTime":"2026-01-23 22:57","pubTimestamp":1769180243,"startTime":"0","endTime":"0","summary":"北京时间2026年01月23日22时57分，苏轩堂股票出现波动，股价快速下跌5.18%。截至发稿，该股报0.086美元/股，成交量99.3221万股，换手率0.78%，振幅5.29%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。苏轩堂股票所在的制药行业中，整体跌幅为0.50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123225723953e1e50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123225723953e1e50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SXTC","BK4007"],"gpt_icon":0},{"id":"2605407107","title":"Whitehawk Therapeutics, Inc.盘中异动 股价大跌5.61%报2.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605407107","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605407107?lang=zh_cn&edition=full","pubTime":"2026-01-23 22:52","pubTimestamp":1769179945,"startTime":"0","endTime":"0","summary":"北京时间2026年01月23日22时52分，Whitehawk Therapeutics, Inc.股票出现波动，股价急速下跌5.61%。Whitehawk Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Revelation Biosciences, Inc.、Coherus Oncology, Inc.、Revelation Biosciences Inc C/Wts 10/01/2027 涨幅较大，Revelation Biosciences, Inc.、60 Degrees Pharmaceuticals, Inc.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为525.66%、88.16%、16.15%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 26/02/2026、Revelation Biosciences, Inc.、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为60.41%、33.94%、26.67%。Whitehawk Therapeutics, Inc.公司简介：Whitehawk Therapeutics Inc 是一种临床前阶段的肿瘤治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123225226a6a59661&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123225226a6a59661&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","WHWK","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"2605470620","title":"诺和诺德明星减肥药上市首周，处方量达18410份","url":"https://stock-news.laohu8.com/highlight/detail?id=2605470620","media":"财闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605470620?lang=zh_cn&edition=full","pubTime":"2026-01-23 20:49","pubTimestamp":1769172560,"startTime":"0","endTime":"0","summary":"数据显示，Wegovy减肥药在上市后的前四天内，处方量就达到了3071份。诺和诺德的Wegovy减肥药于2021年6月获得美国FDA批准上市，成为全球首个获批用于慢性体重管理的GLP-1受体激动剂类药物。分析师认为，Wegovy的上市表现强劲，有望在减肥药市场占据一席之地。目前全球减肥药市场规模超过200亿美元，市场前景广阔。诺和诺德、礼来等制药巨头纷纷布局，竞争日趋激烈。未来几年，随着更多创新减肥药物的上市，市场格局有望重塑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123205314a6a53866&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123205314a6a53866&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","IE00BZ1G4Q59.USD","BK4532","LU0154236417.USD","NVO","BK4007","LU1093756325.SGD","BK4585","LU1093756168.USD","BK4588","IE00BKVL7J92.USD"],"gpt_icon":1},{"id":"1108541126","title":"Relmada Therapeutics公司：Leerink Partners将评级上调至“跑赢大盘”，目标价大幅提升至8美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1108541126","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108541126?lang=zh_cn&edition=full","pubTime":"2026-01-23 19:57","pubTimestamp":1769169443,"startTime":"0","endTime":"0","summary":"投资银行Leerink Partners宣布，将其对生物制药公司Relmada Therapeutics, Inc.的股票评级从“与大盘持平”上调至更高的“跑赢大盘”。与此同时，该机构将其目标股价从之前的1美元大幅上调至8美元，显示出对该公司未来前景的显著看好。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD","BK4007"],"gpt_icon":0},{"id":"2605082284","title":"千亿糖尿病药市场，谁主沉浮？","url":"https://stock-news.laohu8.com/highlight/detail?id=2605082284","media":"医药地理","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605082284?lang=zh_cn&edition=full","pubTime":"2026-01-23 17:56","pubTimestamp":1769162186,"startTime":"0","endTime":"0","summary":"糖尿病药物作为全球慢病管理的核心治疗手段，其市场规模在持续扩容与迭代，传统药物与新疗法在院内外渠道共同勾勒出该领域格局。中国医药工业信息中心PDB数据显示，2025年Q1-Q3，国内全渠道市场糖尿病治疗药物销售额达887亿元。根据PDB数据显示，近三年糖尿病用药市场呈现连续增长，除MAT22Q3因第六批胰岛素专项集采带来过销售额回落，MAT23Q3、MAT24Q3和MAT25Q3分别增长2.41%、7.83%、4.19%，整体市场增长强劲。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123202432a44e75cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123202432a44e75cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVO","02359","BK4599","LU0154236417.USD","603259","LU1093756168.USD","LU1093756325.SGD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","03320","BK4585","BK4007","BK4588","BK4532"],"gpt_icon":1},{"id":"2605247377","title":"直击达沃斯丨医渡科技(02158)、文莱卫生部、诺华基金会宣布启动AI驱动的国家级心血管疾病防控项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2605247377","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605247377?lang=zh_cn&edition=full","pubTime":"2026-01-23 17:30","pubTimestamp":1769160649,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，2026年世界经济论坛年会上，诺华公司董事会主席Giovanni Caforio博士宣布一项重要合作：诺华基金会、文莱卫生部、医渡科技旗下EVYD公司将联合实施数智驱动的心血管疾病防控项目——CARDIO4Cities。当前，心血管疾病及其他非传染性疾病已成为全球死亡的主要原因，占比超70%。文莱国内心血管疾病更是主要死亡原因，给当地公共卫生体系带来持续压力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1396716.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0002141913.USD","IE00BJT1NW94.SGD","LU0320765489.SGD","IE00B2B36J28.USD","02158","IE00BJJMRZ35.SGD","BK4588","BK1189","LU0208291251.USD","IE00B4R5TH58.HKD","IE0009355771.USD","BK4007","BK1617","BK1518","NVS","LU0070302665.USD","LU0211331839.USD","BK4585","IE00BFTCPJ56.SGD","BK4578","BK4532"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0035},{"period":"1month","weight":-0.0017},{"period":"3month","weight":0.0177},{"period":"6month","weight":0.0818},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.0107}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"name":"制药","nameEN":"BK4007"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"制药(BK4007)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供制药(BK4007)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"制药,BK4007,制药股票,制药股票老虎,制药股票老虎国际,制药行情,制药股票行情,制药股价,制药股市,制药股票价格,制药股票交易,制药股票购买,制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"制药(BK4007)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供制药(BK4007)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}